Cutaquig Solution
Product Images NDC 68982-810

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Cutaquig (NDC 68982-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

This image shows a text formula for calculating the initial weekly dose of immunoglobulin therapy. It specifies that the initial weekly dose equals the previous IGIV dose in grams multiplied by 1.30, divided by the number of weeks between IGIV doses. The context relates to dosing guidance for immunoglobulin products.*

FDA Label Image

Image File (Img0002)

A data table showing weight-adjusted dose increments (mL) of Cutaquig (immunoglobulin G) solution for subcutaneous use, organized by difference from target serum IgG trough level (50, 100, 200, 300 mg/dL), dosing frequency (weekly or every other week), and body weight categories (30, 50, 70, 90, 110 kg). The table provides dosing guidance for various patient weights and serum IgG levels.*

FDA Label Image

Image File (Img0003)

An instructional illustration showing a person washing their hands under running water from a faucet, emphasizing hand hygiene before use of a medical product.*

FDA Label Image

Image File (Img0004)

An instructional illustration showing hands removing a cap from a small vial, likely depicting preparation steps for administering a medication such as Cutaquig subcutaneous immunoglobulin solution.*

FDA Label Image

Image File (Img0005)

An instructional illustration showing hands holding a vial and inserting a syringe into it, indicated by a downward arrow suggesting the syringe needle piercing the vial for drawing medication.*

FDA Label Image

Image File (Img0006)

An instructional illustration showing two hands preparing a syringe connected to a thin tube, suggesting the setup for subcutaneous administration. The syringe is held in the right hand while the left hand manages the tubing.*

FDA Label Image

Image File (Img0007)

An instructional diagram illustrating recommended subcutaneous injection sites on a human body. The front and back views highlight areas on the abdomen, thighs, upper arms, and upper back with color-coded regions indicating appropriate locations for subcutaneous administration.*

FDA Label Image

Image File (Img0008)

Illustration showing a close-up of a person preparing to self-administer a subcutaneous injection in the abdominal area, relevant for a subcutaneous solution drug such as Cutaquig (immunoglobulin G) 165 mg/mL by Octapharma USA Inc.*

FDA Label Image

Image File (Img0009)

An instructional illustration showing hands preparing a subcutaneous injection site on the abdomen. One hand is applying a small adhesive dressing after inserting a thin tube or needle under the skin, with tubing connected for administration, likely representing subcutaneous infusion of Cutaquig (immunoglobulin G) solution.*

FDA Label Image

Image File (Img0010)

Illustration showing a subcutaneous infusion site on the abdomen secured with a medical adhesive patch, with tubing connected for delivery of a solution. The image suggests administration of a subcutaneous infusion, consistent with delivery of Cutaquig (immunoglobulin G) solution.*

FDA Label Image

Image File (Img0011)

A data table showing the in vitro reduction factor (log10) for various production steps against enveloped viruses (HIV-1, PRV, SBV) and non-enveloped viruses (MEV, PPV). It details values for ethanol fractionation, S/D treatment, and pH treatment with a global reduction factor calculated for each virus.*

FDA Label Image

Image File (Img0012)

An instructional illustration showing a person washing their hands under running water from a faucet. The image depicts hand hygiene, with water flowing onto the palm.*

FDA Label Image

Image File (Img0013)

An instructional illustration showing hands peeling the protective seal off a vial, demonstrating preparation steps for administration. This image can be associated with Cutaquig, immunoglobulin G subcutaneous solution 165 mg/mL by Octapharma USA Inc.*

FDA Label Image

Image File (Img0014)

An instructional illustration showing a person holding a vial and a syringe, demonstrating the technique of drawing medication from the vial into the syringe by pulling down the plunger. The background is light blue, and the hands are depicted with natural skin tone. An arrow indicates the direction to pull the plunger.*

FDA Label Image

Image File (Img0015)

An illustration showing two hands holding a medical syringe and tubing, likely demonstrating the setup or administration process for a subcutaneous injection. The image appears instructional without textual details.*

FDA Label Image

Image File (Img0016)

An anatomical illustration showing recommended subcutaneous injection sites on the front and back of a male torso and legs. Blue shaded areas indicate preferred injection locations on the upper arms, abdomen, upper back, and thighs. Green shaded areas highlight additional injection sites on the abdomen and upper front thighs.*

FDA Label Image

Image File (Img0017)

An illustration showing a close-up of a person's abdomen, with a hand pinching the skin just above the waistband of pants secured by a belt. The image suggests preparation for a subcutaneous injection, consistent with usage instructions for subcutaneous solution products like Cutaquig immunoglobulin G.*

FDA Label Image

Image File (Img0018)

An instructional illustration depicting hands preparing a subcutaneous injection, with one hand holding the skin and the other placing a white adhesive dressing over a needle site, highlighting subcutaneous administration technique. No product packaging or labels are shown.*

FDA Label Image

Image File (Img0019)

Illustration showing a subcutaneous infusion setup on a person's abdomen. A thin catheter or tube is inserted under the skin, secured with an adhesive dressing consisting of a white tape with holes. The tubing connects to a device or infusion line, demonstrating administration of a subcutaneous solution such as immunoglobulin G.*

FDA Label Image

Image File (Img0020)

Label for Cutaquig 1 g/6 mL immunoglobulin G subcutaneous solution, 16.5% strength, by Octapharma USA Inc. The label includes product storage information, manufacturer details, and active ingredient composition per 1 mL, along with cautionary notes for subcutaneous use and handling instructions.*

FDA Label Image

Image File (Img0021)

Carton packaging label for Cutaquig 165 mg/mL solution, immunoglobulin G, subcutaneous use. Contains 10 mL (1.65 g) per vial. Manufactured by Octapharma, made in Austria, and distributed by Octapharma USA Inc. Label includes storage instructions, composition details, and a barcode.*

FDA Label Image

Image File (Img0022)

Packaging label for Cutaquig 2 g/12 mL solution of immunoglobulin G (human) 16.5% subcutaneous use by Octapharma USA Inc. The label includes storage instructions, ingredients per mL, manufacturer and distributor information, and a barcode. It states no preservative is included and highlights the product's protein content and excipients.*

FDA Label Image

Image File (Img0023)

Cutaquig 3.3 g/20 mL solution for subcutaneous use, containing immune globulin G 16.5%, labeled for storage and usage instructions. The packaging features detailed product information including ingredients, manufacturer (Octapharma USA Inc), and barcode. The label highlights the product as a plasma derivative with a 165 mg/mL protein content and includes cautions for subcutaneous administration only.*

FDA Label Image

Image File (Img0024)

Cutaquig 4 g/24 mL subcutaneous solution (immune globulin G 16.5%) packaging label by Octapharma USA Inc. The label presents product storage conditions, composition including polysorbate 80 and maltose contents, and manufacturer information. It states the product is for subcutaneous use only, prescription-only, sterile, preservative-free, and provides barcode and contact details.*

FDA Label Image

Image File (Img0025)

Label for Cutaquig 8 g/48 mL solution, a subcutaneous immune globulin G product containing 165 mg/mL protein concentration. The label states it is solvent/detergent and pH4 treated, manufactured by Octapharma in Austria, distributed by Octapharma USA Inc. Storage instructions include refrigeration guidelines and warnings against freezing. Ingredients per mL include human normal immunoglobulin G, maltose, polysorbate 80, and water for injection. The label is for Rx use only and specifies the product is sterile without preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.